# NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101

> **NCT05984810** · PHASE2 · RECRUITING · sponsor: **Leiden University Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Pancreas Adenocarcinoma

## Interventions

- **PROCEDURE:** Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101

## Key facts

- **NCT ID:** NCT05984810
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-18
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05984810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05984810, "NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05984810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*